ATRA

Atara Biotherape

• PR Newswire·1d ago

  Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

• PR Newswire·4d ago

  ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

• PR Newswire·5d ago

  Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

• PR Newswire·04/01 13:00

  Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights - ATRA

• TipRanks·03/30 13:10

  Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)

• PR Newswire·03/29 22:12

  ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

• TipRanks·03/27 18:11

  Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects

• PR Newswire·03/24 20:55

  ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

• TipRanks·03/17 20:20

  Atara Biotherapeutics files to sell 400K shares of common stock for holders

• Seeking Alpha·03/17 15:48

  Atara Biotherapeutics GAAP EPS of $2.61 beats by $4.06, revenue of $120.8M

• TipRanks·03/17 12:00

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Atara Biotherapeutics (ATRA), DocGo (DCGO) and Gilead Sciences (GILD)

• Dow Jones·03/16 20:14

  *Correct: Atara Biotherapeutics FY25 Commercialization Revenue $120.8M

• Dow Jones·03/16 20:13

  *Atara Biotherapeutics 4Q Commercialization Revenue $120.8M

• Dow Jones·03/16 20:13

  *Atara Biotherapeutics 4Q Loss/Shr 25c >ATRA

• Reuters·03/16 20:05

  ATARA BIOTHERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND OPERATIONAL PROGRESS